• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妥尔油脂肪酸聚氧乙烯醚(Tyloxapol)非离子脂质体的配方,用于包裹、稳定和溶解抗结核药物。

Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.

机构信息

Department of Chemistry and Center of Advanced Studies in Chemistry, Panjab University, Chandigarh, India.

出版信息

Colloids Surf B Biointerfaces. 2013 Jan 1;101:434-41. doi: 10.1016/j.colsurfb.2012.07.006. Epub 2012 Jul 17.

DOI:10.1016/j.colsurfb.2012.07.006
PMID:23010052
Abstract

The present study delineates the formulation of niosomes from biocompatible surfactant Tyloxapol and their potential as drug delivery system for anti-tuberculosis drugs. Drug loaded niosomes have a size of 150 nm with a loading efficiency of 97.95±0.2, 98.89±0.2 and 99.50±0.2% for rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), respectively. Fourier transform infrared spectroscopic studies infer that the drugs are in harmony with the fabricated niosomes since no visible interactions between the drug and niosomes have been detected. The prepared formulations are quite stable as assessed using absorption spectroscopy. TEM images and photoluminescence results reveal that RIF and INH are located in the film bilayer whereas PZA is adsorbed mainly on the surface head groups. In vitro dissolution studies at physiological conditions have been undertaken to compare the release behavior of drugs from the prepared niosomes. Sustained release has been achieved for hydrophilic drugs and an acceptable release in case of RIF. Comparison of regression coefficients of different kinetic models reveal that INH release follows Fickian diffusion mechanism whereas RIF and PZA, a non-Fickian release mechanism. Such a versatile system is expected to reduce dose-related drug toxicity and reach the atelectatic areas.

摘要

本研究从生物相容性表面活性剂 Tyloxapol 中描绘了尼奥斯omes 的配方及其作为抗结核药物的药物传递系统的潜力。载药尼奥斯omes 的粒径为 150nm,载药量分别为利福平(RIF)、异烟肼(INH)、吡嗪酰胺(PZA)的 97.95±0.2%、98.89±0.2%和 99.50±0.2%。傅里叶变换红外光谱研究推断,由于药物与尼奥斯omes 之间未检测到可见的相互作用,因此药物与所制备的尼奥斯omes 相协调。使用吸收光谱评估,所制备的制剂非常稳定。TEM 图像和光致发光结果表明,RIF 和 INH 位于膜双层中,而 PZA 主要吸附在表面头基团上。在生理条件下进行了体外溶解研究,以比较从制备的尼奥斯omes 中释放药物的行为。亲水性药物实现了持续释放,而 RIF 的释放则可以接受。不同动力学模型回归系数的比较表明,INH 释放遵循菲克扩散机制,而 RIF 和 PZA 则遵循非菲克释放机制。这种多功能系统有望降低与剂量相关的药物毒性并到达肺不张区域。

相似文献

1
Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.妥尔油脂肪酸聚氧乙烯醚(Tyloxapol)非离子脂质体的配方,用于包裹、稳定和溶解抗结核药物。
Colloids Surf B Biointerfaces. 2013 Jan 1;101:434-41. doi: 10.1016/j.colsurfb.2012.07.006. Epub 2012 Jul 17.
2
Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes.Triton 胶束中抗结核药物的定量研究、稳定性和体外释放研究。
Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):173-9. doi: 10.1016/j.colsurfb.2011.05.018. Epub 2011 May 13.
3
Mixed micelles of Lecithin-Tyloxapol as pharmaceutical nanocarriers for anti-tubercular drug delivery.大豆卵磷脂-吐温 80 混合胶束作为抗结核药物传递的药用纳米载体。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:419-25. doi: 10.1016/j.colsurfb.2013.05.015. Epub 2013 May 17.
4
Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization.疏水性和亲水性抗结核药物在协同增效的Brij 96微乳中的共包封:生物物理特性研究
J Pharm Sci. 2015 Jul;104(7):2203-12. doi: 10.1002/jps.24469. Epub 2015 May 7.
5
Tween-embedded microemulsions--physicochemical and spectroscopic analysis for antitubercular drugs.胶束嵌入型微乳液——抗结核药物的物理化学和光谱分析。
AAPS PharmSciTech. 2010 Mar;11(1):143-53. doi: 10.1208/s12249-009-9356-5. Epub 2010 Jan 20.
6
Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies.微乳液体系中多种抗结核药物的包封:定量分析、稳定性和体外释放研究。
J Pharm Sci. 2010 Apr;99(4):1896-911. doi: 10.1002/jps.21971.
7
Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.一种新型交联聚合物抗结核药物递送系统的配方设计与统计优化
J Pharm Sci. 2008 Jun;97(6):2176-207. doi: 10.1002/jps.21159.
8
Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach.采用热分析和光物理方法探究装载于Brij 96微乳中的抗结核药物的位置。
J Pharm Sci. 2014 Mar;103(3):937-44. doi: 10.1002/jps.23857. Epub 2014 Jan 14.
9
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.固定剂量抗结核复方制剂
Int J Tuberc Lung Dis. 2003 Mar;7(3):289-97.
10
Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.将利福平包封在固体脂质纳米粒系统中以限制其在酸性 pH 下的降解和与异烟肼的相互作用。
Int J Pharm. 2013 Mar 25;446(1-2):106-11. doi: 10.1016/j.ijpharm.2013.02.012. Epub 2013 Feb 11.

引用本文的文献

1
Dual-loaded niosome-dendrimer nanoplatform enhances Tirapazamine delivery to hypoxic breast cancer cells.双负载脂质体-树枝状聚合物纳米平台增强了替拉扎明向缺氧乳腺癌细胞的递送。
Sci Rep. 2025 Aug 11;15(1):29308. doi: 10.1038/s41598-025-14704-7.
2
AgNP-Containing Niosomes Functionalized with Fucoidan Potentiated the Intracellular Killing of in Macrophages.含岩藻依聚糖功能化的银纳米颗粒的非离子表面活性剂囊泡增强了巨噬细胞对[具体对象]的细胞内杀伤作用。 (注:原文中“in Macrophages”前缺失具体被杀伤对象的英文表述)
Int J Mol Sci. 2025 Feb 6;26(3):1366. doi: 10.3390/ijms26031366.
3
Current Advances in Lipid-Based Drug Delivery Systems as Nanocarriers for the Management of Female Genital Tuberculosis.
基于脂质的药物递送系统作为纳米载体用于女性生殖器结核治疗的当前进展
Cureus. 2024 Nov 25;16(11):e74452. doi: 10.7759/cureus.74452. eCollection 2024 Nov.
4
Aripiprazole-loaded niosome/chitosan-gold nanoparticles for breast cancer chemo-photo therapy.用于乳腺癌化学光疗的载阿立哌唑的非离子表面活性剂囊泡/壳聚糖-金纳米粒子
BMC Biotechnol. 2024 Dec 24;24(1):108. doi: 10.1186/s12896-024-00939-1.
5
Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery.囊泡药物递送系统:眼部药物递送的有前景的方法。
Pharmaceuticals (Basel). 2024 Apr 16;17(4):511. doi: 10.3390/ph17040511.
6
Hyaluronic Acid-Targeted Niosomes for Effective Breast Cancer Chemostarvation Therapy.用于有效乳腺癌化学饥饿疗法的透明质酸靶向脂质体
ACS Omega. 2024 Feb 22;9(9):10875-10885. doi: 10.1021/acsomega.3c09782. eCollection 2024 Mar 5.
7
Comparison of cytotoxicity of Miltefosine and its niosomal form on chick embryo model.米替福新及其非离子表面活性剂囊泡形式对鸡胚模型细胞毒性的比较。
Sci Rep. 2024 Jan 30;14(1):2482. doi: 10.1038/s41598-024-52620-4.
8
A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications.载药囊泡作为靶向药物传递策略的综合评价:药物制剂和草药化妆品应用。
Curr Drug Deliv. 2024;21(11):1460-1473. doi: 10.2174/0115672018269199231121055548.
9
Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System.用于分析包含氯法齐明、异烟肼、吡嗪酰胺和利福平的皮肤自乳化双乳剂给药系统中药物组合的高效液相色谱法的开发
Methods Protoc. 2023 Nov 1;6(6):104. doi: 10.3390/mps6060104.
10
The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success.皮肤用自双重乳化药物递送系统的研发:处方前研究是成功的关键。
Pharmaceuticals (Basel). 2023 Sep 25;16(10):1348. doi: 10.3390/ph16101348.